Apyx Medical Corp. is an advanced energy technology company, primarily focusing on the development and commercialization of helium plasma and radiofrequency technology products in the cosmetic and surgical markets. Its flagship product, the Renuvion Cosmetic Technology, leverages helium-derived plasma for precision surgical applications, providing enhanced safety and efficacy in procedures such as skin resurfacing and tissue contraction. Another product, the J-Plasma device, employs radiofrequency energy, targeting soft tissue procedures with minimal thermal damage. Founded in 1982, Apyx Medical Corp. has positioned itself as a leader in innovation within the aesthetic surgery sector, catering to medical professionals and specialists seeking cutting-edge, minimally invasive solutions. The company's continued commitment to research and development underpins its strategic growth in both domestic and international medical markets, reinforcing its significance as a pioneer in enhancing surgical outcomes.
Industry average